Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines

Documenti analoghi

• Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
  di: Siddiqui, Mariah, et al.
  Pubblicazione: (2021)
• Can Pioglitazone Safeguard Patients of Lichen Planus Against Homocysteine Induced Accelerated Cardiovascular Aging and Reduced Myocardial Performance: A Systematic Review
  di: Balani, Prachi, et al.
  Pubblicazione: (2020)
• The Relationship of Rapid Eye Movement Sleep Behavior Disorder and Freezing of Gait in Parkinson’s Disease
  di: Nobleza, Chelsea Mae N, et al.
  Pubblicazione: (2020)
• A Review of Pirfenidone as an Anti-Fibrotic in Idiopathic Pulmonary Fibrosis and Its Probable Role in Other Diseases
  di: Shah, Parth V, et al.
  Pubblicazione: (2021)
• The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
  di: Raffaelli, Bianca, et al.
  Pubblicazione: (2018)